Images List Premium Download Classic

Breast Cancer

Breast Cancer-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Method of diagnosing breast cancer, monitoring treatment of breast cancer, and treating breast cancer
University Of Cincinnati
February 15, 2018 - N°20180044738

Described are methods of detecting circulating hotair in breast cancer patients. The detection of circulating hotair may aid in the treatment of triple-negative breast cancer (“tnbc”) or anti-estrogen resistant breast cancer. Circulating hotair may be quantified before and after treatment to determine effectiveness of the treatment. Aspects are directed to diagnosing and treating tnbc and/or ...
Histone demethylase inhibitors
Celgene Quanticel Research, Inc.
February 15, 2018 - N°20180044334

The present disclosure relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted pyridine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, ...
Histone demethylase inhibitors
Celgene Quanticel Research, Inc.
February 15, 2018 - N°20180044296

The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted amidopyridine or amidopyridazine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, ...
Breast Cancer Patent Pack
Download 198+ patent application PDFs
Breast Cancer Patent Applications
Download 198+ Breast Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Breast Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Apparatus and method for determining prognosis of breast cancer and whether to use chemotherapy
Industry-academic Cooperation Foundation, Yonsei University
February 08, 2018 - N°20180038866

The present invention relates to an apparatus and a method for determining breast cancer prognosis and whether to use chemotherapy, and more specifically, to an apparatus and method capable of predicting prognosis and chemotherapeutic effects, which are necessary in determining a treatment plan for a breast cancer patient, by use of progesterone receptor immunostaining results and ki67 protein immunostaining results. ...
Novel peptides and combination of peptides for use in immunotherapy against various tumors
Immatics Biotechnologies Gmbh
February 08, 2018 - N°20180037627

A method of treating a patient who has hepatocellular carcinoma (hcc), colorectal carcinoma (crc), glioblastoma (gb), gastric cancer (gc), esophageal cancer, nsclc, pancreatic cancer (pc), renal cell carcinoma (rcc), benign prostate hyperplasia (bph), prostate cancer (pca), ovarian cancer (oc), melanoma, breast cancer (brca), cll, merkel cell carcinoma (mcc), sclc, non-hodgkin lymphoma (nhl), aml, gallbladder cancer and cholangiocarcinoma (gbc, ccc), urinary ...
Novel peptides and combination of peptides for use in immunotherapy against various tumors
Immatics Biotechnologies Gmbh
February 08, 2018 - N°20180037626

A method of treating a patient who has hepatocellular carcinoma (hcc), colorectal carcinoma (crc), glioblastoma (gb), gastric cancer (gc), esophageal cancer, nsclc, pancreatic cancer (pc), renal cell carcinoma (rcc), benign prostate hyperplasia (bph), prostate cancer (pca), ovarian cancer (oc), melanoma, breast cancer (brca), cll, merkel cell carcinoma (mcc), sclc, non-hodgkin lymphoma (nhl), aml, gallbladder cancer and cholangiocarcinoma (gbc, ccc), urinary ...
Breast Cancer Patent Pack
Download 198+ patent application PDFs
Breast Cancer Patent Applications
Download 198+ Breast Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Breast Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamides and n-(4- hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamides and ...
Pimco 2664 Limited
February 08, 2018 - N°20180037544

The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain substituted n-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and n-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamide compounds (collectively referred to herein as hmc compounds) that are useful, for example, in the treatment of disorders (e. G., diseases) including, inflammation and/or joint destruction ...
Riluzole prodrugs and their use
Biohaven Pharmaceutical Holding Company Ltd.
February 08, 2018 - N°20180036290

Pharmaceutical compositions of the invention include substituted riluzole prodrugs useful for the treatment of cancers including melanoma, breast cancer, brain cancer, and prostate cancer through the release of riluzole. Prodrugs of riluzole have enhanced stability to hepatic metabolism and are delivered into systemic circulation by oral administration, and then cleaved to release riluzole in the plasma via either an enzymatic ...
Zeaxanthin for tumor treatment
The New York Eye And Ear Infirmary
February 08, 2018 - N°20180036257

A composition comprising a pharmaceutically effective amount of zeaxanthin or its derivative for use in treating a malignant tumor and a method of using a pharmaceutically effective amount of zeaxanthin or its derivative either alone or together with one or more pharmaceutical agents for treating a malignant tumor. The tumor may be, but is not limited to breast cancer, cervix ...
Entropy-based radiogenomic descriptors on magnetic resonance imaging (mri) for molecular characterization of breast cancer
Case Western Reserve University
February 01, 2018 - N°20180033138

Methods, apparatus, and other embodiments distinguish disease phenotypes and mutational status using co-occurrence of local anisotropic gradient orientations (coliage) and laws features. One example apparatus includes a set of circuits that acquires a radiologic image (e. G., mri image) of a region of tissue demonstrating breast cancer, computes a gradient orientation for a pixel in the mri image, computes a ...
Inhibitors of lysine specific demethylase-1
Celgene Quanticel Research, Inc.
February 01, 2018 - N°20180028508

The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of lysine specific demethylase-1. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, ...
Bispecific anti-her2 antibody
Beijing Mabworks Biotech Co. Ltd
January 25, 2018 - N°20180022820

The present invention relates to humanized bispecific anti-her2 antibodies that comprise one antigen binding site containing variable regions of heavy and light chain of trastuzumab, and another antigen binding site containing variable regions of heavy and light chain of pertuzumab. The bispecific anti-her2 antibodies is effective for treating cancer, such as breast cancer, gastric cancer, or ovarian cancer. Preferred bispecific ...
Modulators of the p70s6 kinase for use in the treatment of brain disorders and ...
January 25, 2018 - N°20180022735

And wherein, in each substituent consisting of or containing c1-4 hydrocarbyl, the c1-4 hydrocarbyl is selected from c1-4 alkyl, c2-4 alkenyl, c2-4 alkynyl, cyclopropyl, cyclobutyl and cyclopropylmethyl.
Breast Cancer Patent Pack
Download 198+ patent application PDFs
Breast Cancer Patent Applications
Download 198+ Breast Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Breast Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Breast cancer post treatment support garment
January 18, 2018 - N°20180014579

A garment for a wearer having breasts and an under bust located directly under the breasts, and further having a torso, includes a band configured to fit at the under bust of the wearer; a cup extending from the band, the cup including an outer layer and an inner layer that is interior to the outer layer. The garment further ...
Antihistamine for use in treatment of breast cancer
Belina Pharma Ab
January 11, 2018 - N°20180008588

Disclosed herein is desloratadine or ebastin for use in treatment of a patient diagnosed with breast cancer. Also disclosed is desloratadine or ebastin for use in treatment of a patient diagnosed with a cancer type susceptible to immunotherapy.
Thermography-based breast cancer screening using a measure of symmetry
Niramai Health Analytix Pvt. Ltd.
January 04, 2018 - N°20180000461

What is disclosed is a system and method for breast cancer screening which determines whether hot spots, as seen in a thermal image of both breasts, can be classified as possibly malignant based on a measure of symmetry. A thermographic image of both breasts of a patient is received and analyzed to determine whether there exists, in each of a ...
Method for the prognosis and treatment of cancer metastasis
Institució Catalana De Recerca I Estudis Avancats
December 28, 2017 - N°20170370935

The present invention relates to a method for the prognosis of bone metastasis in triple negative (including basal-like) breast cancer or, alternatively, er+ breast cancer (including luminal a and b) which comprises determining if the c-maf gene is amplified in a primary tumor sample. Likewise, the invention also relates to a method for determining the tendency to develop bone metastasis ...
Therapeutic compositions for breast cancer containing protein kinase d1 inhibitor
Sookmyung Women's University Industry Academic Cooperation Foundation
December 28, 2017 - N°20170369887

A method of inhibiting the growth of cancer stem cells, including administering an effective amount of a protein kinase d1 expression or activity inhibitor as an active ingredient to a subject having cancer is provided. Further, a method of treating cancer, including administering an effective amount of a protein kinase d1 expression or activity inhibitor, and antitumor agent as active ...
Device and methods for broadbeam and microbeam chemo-radiosurgery combined with its tumor exosome apheresis
December 28, 2017 - N°20170368373

Surgery, chemotherapy and broadbeam and microbeam radiosurgery releases billions of abscopal metastasis causing, tumor specific plasma soluble proteins, cell membranes, apoptotic bodies, dna and rnas, exosomes like telomere-telomerase, atm-atm kinase and others. They and adaptive resistance to chemo-radiosurgery, paraneoplastic and non-paraneoplastic diseases causing immune complexes are removed by pulse flow combined continuous flow ultracentrifugation apheresis and immune affinity chromatography. Chemotherapy ...
Ar+ breast cancer treatment methods
Radius Health, Inc.
December 28, 2017 - N°20170368036

A method for treating ar+ breast cancer in a subject comprising administering to the subject an ar agonist (e. G., sarms such as rad140), or in combination with one or more therapeutic agents selected from the group consisting of cdk4/6 inhibitors, m-tor inhibitors, pi3k inhibitors, parp inhibitors, bcl-2 inhibitors, and mcl-1 inhibitors.
Selective androgen receptor degrader (sard) ligands and methods of use thereof
University Of Tennessee Research Foundation
December 28, 2017 - N°20170368003

This invention is directed to pyrrole, pyrazole, imidazole, triazole, and morpholine based selective androgen receptor degrader (sard) compounds including heterocyclic anilide rings and their synthetic precursors, r-isomers, and non-hydroxylated and/or non-chiral propanamides, and pharmaceutical compositions and uses thereof in treating prostate cancer, advanced prostate cancer, castration resistant prostate cancer, triple negative breast cancer, other cancers expressing the androgen receptor, ...
Loading